HEMOSTASIS AND THROMBOSIS RESEARCH SOCIETY INC
Income Statement
Fiscal Year: 2024
Jan 1, 2024 – Dec 31, 2024
Revenues in 2024
$1,702,831
Contributions
66%
Program Services
27%
Investments
7%
Other
<1%
Government Grants
0%
Fundraising Events
0%
Membership Dues
0%
Expenses in 2024
$1,825,354
Grants
40%
Other
25%
Fees to Service Providers
19%
Salaries & Benefits
15%
Offices, Occupancy & IT
1%
Advertising & Promotion
<1%
Benefits to Members
0%
Interest
0%
Depreciation
0%
Revenues
2023
2024
Change
Contributions
$2,010,156
$1,128,036
-44%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$571,170
$451,344
-21%
Membership Dues
$0
$0
-
Investments
$84,173
$117,756
+40%
Other
$3,118
$5,695
+83%
Total Revenues
$2,668,617
$1,702,831
-36%
Expenses
2023
2024
Change
Grants
$979,549
$736,821
-25%
Benefits to Members
$0
$0
-
Salaries & Benefits
$272,888
$280,395
+3%
Fees to Service Providers
$321,512
$340,053
+6%
Advertising & Promotion
$181
$1,000
+452%
Offices, Occupancy & IT
$40,028
$19,634
-51%
Interest
$0
$0
-
Depreciation
$0
$0
-
Other
$935,517
$447,451
-52%
Total Expenses
$2,549,675
$1,825,354
-28%
Net income
2023
2024
Change
Net income
+$118,942
-$122,523
-203%
Functional Expenses
Summary
2023
2024
Change
Program
$2,095,035
$1,394,746
-33%
Admin
$453,594
$430,608
-5%
Fundraising
$1,046
$0
-100%
Total Expenses
$2,549,675
$1,825,354
-28%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)